The next phase of the obesity drug race
US$ 25.09
asa glp-1 agonist guidelines Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement Perioperative management of patients taking
Description
Always refer to the individual SmPC for specific guidance
Which medication has fewer side effects
Methods The Society for Perioperative Assessment and Quality Improvement (SPAQI) tasked a multidisciplinary group with developing recommendations for preoperative and postoperative management of patients taking GLP-1 RAs
Current Opinion in Endocrinology, Diabetes, and Obesity, 21(5), 358362
Some of the reasons might be the known adverse effects of GLP-1, which are mainly gastrointestinal, and the injectable route of administration of GLP-1RA prescribed at the time of the study [8]
Additionally, oral semaglutide offers convenience for patients who prefer not to use injections
